Why Welch Allyn RetinaVue can benefit your practice and patients?

More than one million people will develop in their lifetime a form a diabetic retinopathy, an eye disorder that affects those with diabetes and causes vision impairment. Diabetic retinopathy is a leading cause of blindness in working-age adults and it unfortunately often goes undetected until it is too late and the damage is already done. This doesn’t have to be the case, however. If detected early, you can prevent around 95 percent of vision loss in patients diagnosed with this eye disease. You just need the right equipment at your practice to provide effective and affordable diabetic retinopathy screening.

The Welch Allyn RetinaVue Network allows you to easily incorporate retinal exams during primary care, doubling patient compliance rates and increasing revenue for your practice. It’s an affordable solution for patients, as many common health-care plans offer reimbursement for screenings. The national average reimbursement for using the service is 75 dollars per exam, which means the RetinaVue Network is affordable for your clinic as well.

The RetinaVue Network uses a simple, four-step process to screen patients and provide accurate results. First, an image is acquired using an automated non-mydriatic camera. The image is then sent to a board-certified retinal specialist through a secure network. The image is evaluated by this specialist, and that same day, the a diagnostic report and management plan is sent back to the provider. The results are typically returned in just 90 minutes.

Invest in medical equipment that benefits both your patients and the practice. The Welch Allyn RetinaVue 100 Imager can be purchased or leased through Medical Device Depot today.

Leave a Reply